logo

For the Inventor, By the Inventor

Osaka, Japan

Hiroshi Fukase

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 51(Granted Patents)


Location History:

  • Osaka, JA (1977)
  • Osaka, JP (1984 - 1991)

Company Filing History:

goldMedal12 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents

Years Active: 1977-1991

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5004838 - Inosose derivatives, production and use thereof (1991-04-02),
2. 4898986 - Inosose derivatives, production and use thereof (1990-02-06),
3. 4824943 - Inosose derivatives and production thereof (1989-04-25),
4. 4803303 - N-substituted pseudo-aminosugars, their production and use (1989-02-07),
5. 4777294 - N-substituted pseudo-aminosugars, their production and use (1988-10-11),
6. 4701559 - N-substituted pseudo-aminosugars, their production and use (1987-10-20),
7. 4595678 - N-substituted pseudo-aminosugars and pharmaceutical compositions (1986-06-17),
8. 4486602 - Valienamine derivatives, their production and use (1984-12-04),
9. 4465844 - Alanyl-2-(5-hydroxy-2-oxo-pyrrolidin-3-yl)glycine (1984-08-14),
10. 4446319 - Aminocyclitols and their production (1984-05-01),
11. 4436918 - Method for production of peptide, and its intermediate (1984-03-13),
12. 4017485 - 7-Methoxycephalosporin derivatives (1977-04-12),

Title: The Innovations of Hiroshi Fukase: A Pioneer in Inosose Derivatives

Introduction

Hiroshi Fukase is an esteemed inventor based in Osaka, Japan, known for his significant contributions to the field of chemical innovation. With a remarkable portfolio comprising 12 patents, Fukase has dedicated his career to exploring new compounds that address critical health issues.

Latest Patents

Among his latest inventions is the patent related to inosose derivatives, which details a novel inosose compound represented by a specific general formula. This compound, characterized by halogen substitutions and potential protective groups for hydroxyl, plays a pivotal role in producing valiolamine and its N-substituted derivatives. These derivatives exhibit potent alpha-glucosidase inhibiting activities, proving beneficial as preventives or therapeutics for hyperglycemia and related diseases such as diabetes, obesity, and hyperlipemia in both humans and animals.

Career Highlights

Hiroshi Fukase is currently affiliated with Takeda Chemical Industries, Inc., a global leader in the biopharmaceutical sector. His innovative work is recognized not only for its scientific merit but also for its potential impact on public health. His contributions to the synthesizing of compounds that could mitigate serious health conditions further cement his reputation as a leading inventor in his field.

Collaborations

Fukase has collaborated with notable colleagues such as Satoshi Horii and Yukihiko Kameda, working closely with them to push the boundaries of chemical innovation. These collaborations have likely facilitated a dynamic exchange of ideas and expertise, enriching the research and development processes within their field.

Conclusion

Hiroshi Fukase exemplifies the spirit of innovation that drives progress in science and health. His ongoing research and patent developments in inosose derivatives stand as a testament to his commitment to advancing therapeutic options for critical health challenges. As he continues to work at Takeda Chemical Industries, Inc., the impact of his achievements is anticipated to resonate in the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…